Journal of Clinical Endocrinology & Metabolism, Vol 80, 1712-1716, Copyright © 1995 by Endocrine Society

ARTICLES

Effects of stimulatory and inhibitory thyrotropin receptor antibodies on lipolysis in infant adipocytes

A Janson, FA Karlsson, G Micha-Johansson, P Bolme, M Bronnegard and C Marcus
Department of Pediatrics, Huddinge University Hospital, Stockholm, Sweden.

TSH is a potent lipolytic hormone for isolated human adipocytes from neonatal subjects. Crude immunoglobulin fractions from sera of patients with Graves' disease, containing stimulatory TSH receptor (TSHR) autoantibodies, significantly increased lipolysis in fat cells from infants, whereas immunoglobulin fraction from a patient with inhibitory TSHR autoantibodies (TBab) blocked TSH-induced lipolysis in a dose- dependent manner. Although TBab totally blocked the maximum lipolysis induced by TSH (10(5) mU/L), no effect was seen on isoprenaline-induced lipolysis. The maximum lipolytic response to TSH was similar to that seen with the beta-adrenoceptor agonist isoprenaline, and there was a similar cAMP increase in response to both stimulators. From these results, it is concluded that the TSHR in infant adipocytes is likely to be coupled to the adenylate cyclase system, and the lipolytic effect of TSH can be simulated by stimulatory TSHR autoantibodies or inhibited by TBab.

This article has been cited by other articles:

				A. F. Kamel, S. Norgren, K. Strigard, A. Thorne, H. Fakhrai-Rad, J. Galli, and C. Marcus Age-Dependent Regulation of Lipogenesis in Human and Rat Adipocytes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4601 - 4606. [Abstract] [Full Text] [PDF]

				A. Bell, A. Gagnon, P. Dods, D. Papineau, M. Tiberi, and A. Sorisky TSH signaling and cell survival in 3T3-L1 preadipocytes Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1056 - C1064. [Abstract] [Full Text] [PDF]

				R. W. Valyasevi, D. A. Harteneck, C. M. Dutton, and R. S. Bahn Stimulation of Adipogenesis, Peroxisome Proliferator-Activated Receptor-{gamma} (PPAR{gamma}), and Thyrotropin Receptor by PPAR{gamma} Agonist in Human Orbital Preadipocyte Fibroblasts J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2352 - 2358. [Abstract] [Full Text] [PDF]

				B. Rapoport, G. D. Chazenbalk, J. C. Jaume, and S. M. McLachlan The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies Endocr. Rev., December 1, 1998; 19(6): 673 - 716. [Abstract] [Full Text]

				H. Shimura, A. Miyazaki, K. Haraguchi, T. Endo, and T. Onaya Analysis of Differentiation-Induced Expression Mechanisms of Thyrotropin Receptor Gene in Adipocytes Mol. Endocrinol., October 1, 1998; 12(10): 1473 - 1486. [Abstract] [Full Text]

				H. Shimura, K. Haraguchi, T. Endo, and T. Onaya Regulation of Thyrotropin Receptor Gene Expression in 3T3-L1 Adipose Cells is Distinct from Its Regulation in FRTL-5 Thyroid Cells Endocrinology, April 1, 1997; 138(4): 1483 - 1490. [Abstract] [Full Text] [PDF]